Walleye Capital
EVGN icon

Walleye Capital’s Evogene EVGN Stock Holding History

Walleye Capital’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-34,948
Closed -$293K – 5535
2023
Q4 		$293K Sell
34,948
-16,761
-32% -$105K ﹤0.01% 3383
2023
Q3 		$303K Buy
+51,709
New +$453K ﹤0.01% 3232
2022
Q2 		– Sell
-1,134
Closed -$15K – 2473
2022
Q1 		$15K Sell
1,134
-1,370
-55% -$18.5K ﹤0.01% 2020
2021
Q4 		$41K Buy
+2,504
New +$56.8K ﹤0.01% 1803
2021
Q3 		– Sell
-1,898
Closed -$65 – 1656
2021
Q2 		$65 Sell
1,898
-202
-10% -$7.91K ﹤0.01% 1211
2021
Q1 		$106 Buy
+2,100
New +$130K 0.01% 1027

Other funds holding EVGN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Walleye Capital's EVGN Position: Q1 2024 in Review

Walleye Capital sold out of Evogene (EVGN) in Q1 2024, closing a stake of 34,948 shares — an estimated $293K sold.

Walleye Capital first reported a position in EVGN in Q1 2021 and held it in 6 quarters. The position peaked at $303K in Q3 2023. 29 funds tracked by Wall St. Rank hold EVGN as of Q1 2024.

  • Walleye Capital reported no remaining Evogene position as of Q1 2024 after selling out during the quarter.
  • Walleye Capital sold 34,948 Evogene shares in Q1 2024, an estimated $293K.
  • Walleye Capital first reported a position in Evogene in Q1 2021 and held it in 6 quarters.
  • Walleye Capital's Evogene position peaked at $303K in Q3 2023.
  • 29 funds tracked by Wall St. Rank held Evogene as of Q1 2024.

Based on Walleye Capital's 13F filing for Q1 2024, filed 15 May 2024.